This inventor holds 61 USPTO granted patents and 32 published patent applications, plus 9 CIPO patents and 21 EPO patents, primarily in Lipid Nanoparticle Delivery (CPC class A61K). Top assignees: Translate Bio, Inc., Ethris Gmbh, Shire Human Genetic Therapies, Inc.. Active years: 1997-2026.
Inventors with similar research interests:
Location History:
- Concord, MA (US) (1997 - 2022)
- Lexington, MA (US) (2019 - 2024)
- Cambridge, MA (US) (2024)
Company Filing History:
45 out of 172 
7 out of 28 
6 out of 86 
Years Active: 1997-2026
Areas of Expertise:
Title: Braydon Charles Guild: Innovating mRNA Delivery Solutions
Introduction
Braydon Charles Guild is a prominent inventor based in Concord, MA, known for his significant contributions to the field of biotechnology. With an impressive portfolio of 55 patents, Guild has been pivotal in developing innovative solutions for mRNA delivery and lipid nanoparticle compositions that have the potential to revolutionize therapeutic approaches.
Latest Patents
Among his latest patents, Guild has developed lipid nanoparticle compositions and methods for mRNA delivery, which focus on modulating protein production in target cells. These innovative compositions aim to treat diseases associated with protein or enzyme deficiencies. Additionally, his patent on cleavable lipids introduces novel compounds that serve as liposomal delivery vehicles, facilitating the targeted delivery of encapsulated polynucleotides. These compounds are characterized by advantageous properties compared to other similar lipids, underscoring their potential in enhancing transfection efficiencies in target cells.
Career Highlights
Guild has enjoyed a successful career as an inventor and researcher, having worked with renowned companies such as Translate Bio, Inc. and Shire Human Genetic Therapies, Inc. His expertise in biotechnology and passion for innovation have contributed to his prolific output of patents, establishing him as a leader in his field.
Collaborations
Throughout his career, Braydon has collaborated with various professionals, including noteworthy coworkers like Michael W Heartlein and Frank DeRosa. These collaborations have facilitated the exchange of ideas and fostered advancements in the development of cutting-edge biotechnological solutions.
Conclusion
Braydon Charles Guild stands out as a visionary inventor whose work continues to push the boundaries of biotechnology. With his latest patents focusing on mRNA delivery and lipid nanoparticle technology, Guild’s innovations promise to open new avenues for treating complex diseases, highlighting the importance of ongoing research and development in this critical field.